FICC takes aim at return-policy

Uriel Lynn, president of the Federation of Israeli Chambers of Commerce, said Wednesday he is opposed to the proposed return policy rule that Industry, Trade and Labor Minister Eli Yishai presented to the Justice Ministry on Monday.

By MATTHEW KRIEGER
June 7, 2007 07:05

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Uriel Lynn, president of the Federation of Israeli Chambers of Commerce, said Wednesday he is opposed to the proposed return policy rule that Industry, Trade and Labor Minister Eli Yishai presented to the Justice Ministry on Monday. Under the terms of Yishai's proposal, customers will be able to receive their full money back on a return of a purchase so long as the product is not used or damaged and the customer brings it back within 21 days of the purchase date. Lynn claimed the proposed rule would damage business owners and that it contradicts the country's law of sales and contracts.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS